China has achieved a significant medical milestone, with its drug regulator announcing the approval of the country's first domestically developed 9-valent human papillomavirus (HPV) vaccine.
The U.S. FDA has approved Moderna’s next-generation COVID-19 vaccine, mNEXSPIKE, for adults aged 65 and older and those aged 12–64 with risk factors, marking a major step under tighter regulations.
U.S. Health Secretary Robert F. Kennedy Jr. has announced that COVID-19 vaccines will no longer be recommended for healthy children and pregnant women — a move that has sparked sharp criticism from public health experts.
Pakistan kicked off a nationwide anti-polio campaign on Monday, aiming to vaccinate over 45 million children under the age of five as part of efforts to eliminate the crippling disease—one of the last remaining in the world.
The U.S. Food and Drug Administration (FDA) has granted approval to Novavax's COVID-19 vaccine, Nuvaxovid, but with specific conditions limiting its use to certain groups.
Uganda has launched a trial vaccination program for the Sudan strain of Ebola as confirmed cases rise to three. With no approved vaccine for this strain, the trial aims to protect communities and strengthen outbreak response, according to the WHO.
The WHO has approved Abbott Laboratories' mpox diagnostic test for emergency use, marking a key step in boosting testing in outbreak-hit countries. The real-time PCR test detects mpox virus DNA from skin swabs, with more tests under review to increase diagnostic availability worldwide.
Researchers at the University of Oxford are developing OvarianVax, a vaccine aimed at training the immune system to detect early signs of ovarian cancer.
The FDA has approved AstraZeneca's treatment for use outside of healthcare facilities, but it will still require a prescription.
You can download the AnewZ application from Play Store and the App Store.
